CompoAtlas

Otifant

Natural health product licensed in Canada

Licence holder
Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
NPN or DIN-HM
80029818
Status
Inactive licence
Licence date
23 February 2012
Revision date
15 June 2018
Form
Huile
Route of administration
Otique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Verbascum thapsus

Source : Fleur

0.021 mL
Olea europea

Source : Fruit

0.008 mL

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 5 years ; maximum: 18 yearsminimum: 4 Goutte(s) ; maximum: 5 Goutte(s)3 days

Uses authorised in Canada

Otifant contribue à soulager la douleur causée par l'otite moyenne aiguë.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80029818

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line